임상시험 관리 시스템 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2033년)

Clinical Trial Management System Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

US $ 4,995 ￦ 6,876,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,043,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 11,695,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

이 조사 리포트는 2024-2033년 임상시험 관리 시스템(CTMS) 시장을 폭넓게 분석하고 시장 역학, 성장 촉진요인·과제, 동향, 주요 인사이트 등을 종합적으로 해설하고 있습니다. 이해관계자가 전략적의사결정을 실시해, 임상시험 관리의 진화 하는 상황을 탐색하기 위해 필수적인 정보를 제공합니다.

세계의 임상시험 관리 시스템 시장은 예측 기간 중 14.2%의 CAGR로 견고하게 성장하며, 2024년 시장 추산·예측 금액은 25억 달러에서 2033년말까지는 84억 달러로 확대할 것으로 예측됩니다.

주요 인사이트

• 임상시험 관리 시스템 시장 규모(2024년 추산) : 25억 달러
• 시장 예측 금액(2033년 예측) : 84억 달러
• 세계 시장 성장률(CAGR, 2024-2033년) : 14.2%

임상시험 관리 시스템 시장 - 조사 범위 :

임상시험의 복잡화는 엄격한 규제 요건과 함께 임상시험 관리 시스템의 채택을 지원하고 있습니다. CTMS는 효율적인 시험 계획, 참가자 모집, 데이터 관리, 규제 준수를 촉진하여 업무 효율성을 높이고 시험 기간을 단축하며, AI, 머신러닝, 블록체인과 같은 첨단 기술의 통합은 데이터 무결성, 투명성, 안전성을 강화합니다. 기술의 통합은 데이터의 무결성, 투명성, 안전성을 강화하여 시장 성장을 더욱 촉진할 것입니다. 제약 및 생명공학 기업, 위탁연구기관(CRO), 학술연구기관은 임상시험 프로세스를 간소화하고 우수임상시험관리기준(GCP) 가이드라인을 준수하기 위해 CTMS를 널리 활용하고 있습니다.

시장 성장의 촉진요인:

임상시험 관리 시스템 시장의 성장을 가속하는 몇 가지 요인이 있습니다. 만성질환의 유병률 증가와 새로운 치료법에 대한 수요 증가로 인해 전 세계 임상시험 수가 증가하고 있습니다. 맞춤형 의료로의 전환과 생물학적 제제 개발은 다양한 데이터 유형과 복잡한 임상시험 프로토콜을 처리할 수 있는 고급 임상시험 관리 솔루션을 필요로 합니다. 또한 COVID-19 팬데믹으로 인해 가상 임상시험과 분산형 임상시험 접근법의 채택이 가속화되면서 민첩하고 확장성이 뛰어난 CTMS 솔루션의 필요성이 더욱 강조되고 있습니다. 임상연구를 촉진하기 위한 정부의 구상과 임상시험 업무를 CRO에 아웃소싱하는 것도 시장 확대에 기여하고 있습니다.

시장 성장 억제요인 :

임상시험 관리 시스템 시장은 견고한 성장이 예상되지만, 특정 과제에 직면해 있습니다. 특히 중소기업과 학술연구기관은 높은 도입 비용과 기존 임상 시스템과의 통합에 따른 복잡성으로 인해 시장 진입에 어려움을 겪고 있습니다. 특히 데이터 보호 규제가 엄격한 지역에서는 데이터 프라이버시, 환자 기밀성 및 규제 준수에 대한 우려로 인해 클라우드 기반 CTMS 솔루션의 보급이 저해되고 있습니다. 또한 서로 다른 CTMS 플랫폼과 전자의무기록(EHR) 간의 상호운용성 문제는 데이터 교환 및 통합을 복잡하게 만들어 시장 침투를 제한하고 있습니다.

시장 기회 :

임상시험 관리 시스템 시장은 기술 발전과 임상시험 패러다임의 진화로 인해 큰 성장 기회를 맞이하고 있으며, AI와 머신러닝 알고리즘의 통합은 예측 분석, 환자 모집, 시험 결과를 향상시키고 시험 설계 및 의사 결정 프로세스를 최적화할 수 있습니다. 블록체인 기술은 데이터의 무결성, 투명성, 감사 가능성을 보장하여 보안 우려와 규제 요건을 충족시킬 수 있습니다. 또한 모바일 헬스(mHealth) 기술과 웨어러블 기기의 채택은 실시간 데이터 수집, 원격 모니터링 및 환자 참여를 가능하게 하여 임상시험의 분산화를 촉진하고 참여자 유지를 강화할 수 있습니다. 정밀의료에 대한 관심이 확대되고 희귀질환 및 희귀의약품에 대한 관심이 높아짐에 따라 새로운 시장 성장 경로가 생겨나고 있으며, 복잡한 임상시험 프로토콜과 적응형 임상시험 설계를 지원하는 민첩하고 확장성이 뛰어난 CTMS 솔루션이 요구되고 있습니다.

목차

제1장 주요 요약

제2장 시장 개요

• 시장 범위 / 분류
• 시장의 정의 / 범위 / 제한
• 포함 사항·제외 사항

제3장 주요 시장 동향

• 시장에 영향을 미치는 주요 동향
• 혁신 / 개발 동향

제4장 주요 성공요인

• 제품 채택 분석
• 주요 규제
• 최근 제품 승인 / 발매
• 주요 프로모션 전략 : 주요 기업별
• PESTEL 분석
• Porter의 산업 분석
• 밸류체인 분석

제5장 시장 배경

• 거시경제 요인
• 예측 요인 - 관련성과 영향
• 시장 역학

제6장 COVID-19 위기 분석

• COVID-19와 영향 분석
  • 딜리버리 방법별
  • 시스템 유형별
  • 컴포넌트별
  • 최종사용자별
  • 국가별
• 2024년 시장 시나리오

제7장 세계의 임상시험 관리 시스템 시장 수요 분석

• 과거 시장 금액 분석, 2019-2023년
• 현재 및 향후 시장 금액 예측, 2024-2033년
  • 전년대비 성장 동향 분석
  • 절대액의 기회 분석

제8장 세계의 임상시험 관리 시스템 시장 분석 : 딜리버리 방법별

• 서론 / 주요 조사 결과
• 과거 시장 규모 분석 : 딜리버리 방법별, 2019-2023년
• 현재 및 향후 시장 규모 분석과 예측 : 딜리버리 방법별, 2024-2033년
  • 클라우드 기반 임상시험 관리 시스템
  • 웹기반 임상시험 관리 시스템
  • 온프레미스 임상시험 관리 시스템
• 시장의 매력 분석 : 딜리버리 방법별

제9장 세계의 임상시험 관리 시스템 시장 분석 : 시스템 유형별

• 서론 / 주요 조사 결과
• 과거 시장 규모 분석 : 시스템 유형별, 2019-2023년
• 현재 및 향후 시장 규모의 분석과 예측 : 시스템 유형별, 2024-2033년
  • 기업 기반 임상시험 관리 시스템
  • 시설 기반 임상시험 관리 시스템
• 시장의 매력 분석 : 시스템 유형별

제10장 세계의 임상시험 관리 시스템 시장 분석 : 컴포넌트별

• 서론 / 주요 조사 결과
• 과거 시장 규모 분석 : 컴포넌트별, 2019-2023년
• 현재 및 향후 시장 규모의 분석과 예측 : 컴포넌트별, 2024-2033년
  • 하드웨어
  • 서비스
• 시장의 매력 분석 : 컴포넌트별

제11장 세계의 임상시험 관리 시스템 시장 분석 : 최종사용자별

• 서론 / 주요 조사 결과
• 과거 시장 규모 분석 : 최종사용자별, 2019-2023년
• 현재 및 향후 시장 규모의 분석과 예측 : 최종사용자별, 2024-2033년
  • 의약품
  • 임상 조사기관(CRO)
  • 헬스케어 프로바이더
• 시장의 매력 분석 : 최종사용자별

제12장 세계의 임상시험 관리 시스템 시장 분석 : 지역별

• 서론
• 과거 시장 규모 분석 : 지역별, 2019-2023년
• 현재 및 향후 시장 금액의 분석과 예측 : 지역별, 2024-2033년
  • 북미
  • 라틴아메리카
  • 유럽
  • 동아시아
  • 남아시아
  • 오세아니아
  • 중동 및 아프리카(MEA)
• 시장의 매력 분석 : 지역별

제13장 북미의 임상시험 관리 시스템 시장 분석

제14장 라틴아메리카의 임상시험 관리 시스템 시장 분석

제15장 유럽의 임상시험 관리 시스템 시장 분석

제16장 동아시아의 임상시험 관리 시스템 시장 분석

제17장 남아시아의 임상시험 관리 시스템 시장 분석

제18장 오세아니아의 임상시험 관리 시스템 시장

제19장 중동 및 아프리카(MEA) 임상시험 관리 시스템 시장 분석

제20장 시장 구조 분석

• 시장 분석 : 기업 계층별
• 주요 기업의 시장 점유율 분석
• 시장 입지 분석

제21장 경쟁 분석

• 경쟁 대시보드
• 경쟁의 상세 정보
  • Oracle Corporation
  • Merge Healthcare Incorporated
  • Medidata Solutions Inc.
  • PAREXEL International Corporation
  • BioClinica
  • MedNet Solutions, Inc.
  • Bio-Optronics, Inc.
  • DSG, Inc.
  • eClinForce, Inc.
  • Forte Research Systems, Inc.

제22장 사용되는 전제 조건과 두자어

제23장 조사 방법

KSA

영문 목차

영문목차

Market Research Insights offers an extensive analysis of the Clinical Trial Management System (CTMS) Market from 2024 to 2033, providing a comprehensive understanding of market dynamics, growth drivers, challenges, trends, and key insights. This report equips stakeholders with essential information for strategic decision-making and navigating the evolving landscape of clinical trial management.

The global clinical trial management system market is projected to grow at a robust CAGR of 14.2% during the forecast period, expanding from an estimated value of USD 2.5 billion in 2024 to USD 8.4 billion by the end of 2033.

Key Insights:

• Clinical Trial Management System Market Size (2024 Estimate): USD 2.5 Billion
• Projected Market Value (2033 Forecast): USD 8.4 Billion
• Global Market Growth Rate (CAGR 2024 to 2033): 14.2%

Clinical Trial Management System Market - Report Scope:

The increasing complexity of clinical trials, coupled with stringent regulatory requirements, drives the adoption of clinical trial management systems. CTMS facilitates efficient trial planning, participant recruitment, data management, and regulatory compliance, thereby enhancing operational efficiency and reducing trial timelines. The integration of advanced technologies such as AI, machine learning, and blockchain enhances data integrity, transparency, and security, further augmenting market growth. Pharmaceutical and biotechnology companies, contract research organizations (CROs), and academic research institutes extensively utilize CTMS to streamline clinical trial processes and ensure adherence to Good Clinical Practice (GCP) guidelines.

Market Growth Drivers:

Several factors propel the growth of the Clinical Trial Management System Market. The rising prevalence of chronic diseases and the increasing demand for novel therapies drive the number of clinical trials globally. The shift towards personalized medicine and the development of biologics necessitate sophisticated trial management solutions capable of handling diverse data types and complex trial protocols. Furthermore, the COVID-19 pandemic has accelerated the adoption of virtual clinical trials and decentralized trial approaches, emphasizing the need for agile and scalable CTMS solutions. Government initiatives promoting clinical research and the outsourcing of clinical trial activities to CROs further contribute to market expansion.

Market Restraints:

Despite robust growth prospects, the Clinical Trial Management System Market faces certain challenges. High implementation costs and the complexity associated with integrating CTMS with existing clinical systems pose barriers to market entry, particularly for small and medium-sized enterprises (SMEs) and academic research institutes. Concerns regarding data privacy, patient confidentiality, and regulatory compliance hinder widespread adoption of cloud-based CTMS solutions, especially in regions with stringent data protection regulations. Additionally, interoperability issues between different CTMS platforms and electronic health records (EHRs) complicate data exchange and integration, limiting market penetration.

Market Opportunities:

The Clinical Trial Management System Market presents significant growth opportunities driven by technological advancements and evolving clinical trial paradigms. The integration of AI and machine learning algorithms enhances predictive analytics, patient recruitment, and trial outcomes, optimizing trial design and decision-making processes. Blockchain technology ensures data integrity, transparency, and auditability, addressing security concerns and regulatory requirements. Moreover, the adoption of mobile health (mHealth) technologies and wearable devices enables real-time data collection, remote monitoring, and patient engagement, facilitating decentralized clinical trials and enhancing participant retention. The expansion of precision medicine initiatives and the increasing focus on rare diseases and orphan drugs create new avenues for market growth, necessitating agile and scalable CTMS solutions to support complex trial protocols and adaptive trial designs.

Competitive Landscape and Business Strategies:

Prominent companies in the Clinical Trial Management System Market include Oracle Corporation, Medidata Solutions (a Dassault Systemes company), Parexel International Corporation, Veeva Systems, and Bioclinica, Inc. These companies focus on strategic initiatives such as product innovation, partnerships, and mergers and acquisitions to strengthen their market position and expand their product portfolios. By investing in research and development, these players introduce advanced CTMS solutions with enhanced functionalities, scalability, and interoperability, catering to evolving customer requirements and regulatory standards. Furthermore, collaborations with pharmaceutical companies, CROs, and academic research institutions enhance market reach and customer engagement, facilitating sustainable growth and competitive advantage in the global clinical trial management system market.

Key Companies Profiled:

• Oracle Corporation
• Medidata Solutions (a Dassault Systemes company)
• Parexel International Corporation
• Veeva Systems
• Bioclinica, Inc.
• IBM Corporation
• DSG, Inc.
• Bio-Optronics, Inc.
• ArisGlobal LLC
• eClinical Solutions, LLC
• OpenClinica LLC
• Others

Clinical Trial Management System Market Segmentation:

Mode of Delivery:

• Cloud based clinical trial management system
• Web based clinical trial management system
• On-premise clinical trial management system

End-User:

• Pharmaceuticals
• Clinical Research Organizations (CROs)
• Healthcare Providers

Systems Type:

• Enterprise based clinical trial management system
• Site based clinical trial management system

Components:

• Hardware
• Services

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusions and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Innovation / Development Trends

4. Key Success Factors

• 4.1. Product Adoption Analysis
• 4.2. Key Regulations
• 4.3. Recent Product Approvals/Launches
• 4.4. Key promotional Strategies, By Key Players
• 4.5. PESTEL Analysis
• 4.6. Porter's Analysis
• 4.7. Value Chain Analysis

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Global Healthcare Outlook
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Increase in R&D Spending
  • 5.2.2. Product Adoption Rate
  • 5.2.3. Recent Product Launched/approved
  • 5.2.4. Changes in Regulatory Policies
  • 5.2.5. Strategic Collaborations
• 5.3. Market Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

• 6.1. COVID-19 and Impact Analysis
  • 6.1.1. By Mode of Delivery
  • 6.1.2. By System Type
  • 6.1.3. By Component
  • 6.1.4. By End User
  • 6.1.5. By Country
• 6.2. 2024 Market Scenario

7. Global Clinical Trial Management System Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

• 7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
• 7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
  • 7.2.1. Y-o-Y Growth Trend Analysis
  • 7.2.2. Absolute $ Opportunity Analysis

8. Global Clinical Trial Management System Market Analysis 2019-2023 and Forecast 2024-2033, By Mode of Delivery

• 8.1. Introduction / Key Findings
• 8.2. Historical Market Size (US$ Bn) Analysis, By Mode of Delivery, 2019-2023
• 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Mode of Delivery, 2024-2033
  • 8.3.1. Cloud based clinical trial management system
  • 8.3.2. Web based clinical trial management system
  • 8.3.3. On-premise clinical trial management system
• 8.4. Market Attractiveness Analysis By Mode of Delivery

9. Global Clinical Trial Management System Market Analysis 2019-2023 and Forecast 2024-2033, By System Type

• 9.1. Introduction / Key Findings
• 9.2. Historical Market Size (US$ Bn) Analysis, By System Type, 2019-2023
• 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By System Type, 2024-2033
  • 9.3.1. Enterprise based clinical trial management system
  • 9.3.2. Site based clinical trial management system
• 9.4. Market Attractiveness Analysis By System Type

10. Global Clinical Trial Management System Market Analysis 2019-2023 and Forecast 2024-2033, By Component

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Bn) Analysis, By Component, 2019-2023
• 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Component, 2024-2033
  • 10.3.1. Hardware
  • 10.3.2. Services
• 10.4. Market Attractiveness Analysis By Component

11. Global Clinical Trial Management System Market Analysis 2019-2023 and Forecast 2024-2033, By End User

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2023
• 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
  • 11.3.1. Pharmaceuticals
  • 11.3.2. Clinical Research Organizations (CROs)
  • 11.3.3. Healthcare Providers
• 11.4. Market Attractiveness Analysis By End User

12. Global Clinical Trial Management System Market Analysis 2019-2023 and Forecast 2024-2033, By Region

• 12.1. Introduction
• 12.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
• 12.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, By Region 2024-2033
  • 12.3.1. North America
  • 12.3.2. Latin America
  • 12.3.3. Europe
  • 12.3.4. East Asia
  • 12.3.5. South Asia
  • 12.3.6. Oceania
  • 12.3.7. Middle East and Africa (MEA)
• 12.4. Market Attractiveness Analysis By Region

13. North America Clinical Trial Management System Market Analysis 2019-2023 and Forecast 2024-2033

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 13.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
  • 13.3.1. By Country
    • 13.3.1.1. U.S.
    • 13.3.1.2. Canada
  • 13.3.2. By Mode of Delivery
  • 13.3.3. By System Type
  • 13.3.4. By Component
  • 13.3.5. By End User
• 13.4. Market Attractiveness Analysis
  • 13.4.1. By Country
  • 13.4.2. By Mode of Delivery
  • 13.4.3. By System Type
  • 13.4.4. By Component
  • 13.4.5. By End User
• 13.5. Market Trends
• 13.6. Drivers and Restraints - Impact Analysis
• 13.7. Key Players - Intensity Mapping
• 13.8. Country Level Analysis & Forecast
  • 13.8.1. U.S. Clinical Trial Management System Market Analysis
    • 13.8.1.1. Introduction
    • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.1.2.1. By Mode of Delivery
      • 13.8.1.2.2. By System Type
      • 13.8.1.2.3. By Component
      • 13.8.1.2.4. By End User
  • 13.8.2. Canada Clinical Trial Management System Market Analysis
    • 13.8.2.1. Introduction
    • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.2.2.1. By Mode of Delivery
      • 13.8.2.2.2. By System Type
      • 13.8.2.2.3. By Component
      • 13.8.2.2.4. By End User

14. Latin America Clinical Trial Management System Market Analysis 2019-2023 and Forecast 2024-2033

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 14.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
  • 14.3.1. By Country
    • 14.3.1.1. Mexico
    • 14.3.1.2. Brazil
    • 14.3.1.3. Argentina
    • 14.3.1.4. Rest of Latin America
  • 14.3.2. By Mode of Delivery
  • 14.3.3. By System Type
  • 14.3.4. By Component
  • 14.3.5. By End User
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Mode of Delivery
  • 14.4.3. By System Type
  • 14.4.4. By Component
  • 14.4.5. By End User
• 14.5. Market Trends
• 14.6. Drivers and Restraints - Impact Analysis
• 14.7. Key Players - Intensity Mapping
• 14.8. Country Level Analysis & Forecast
  • 14.8.1. Mexico Clinical Trial Management System Market Analysis
    • 14.8.1.1. Introduction
    • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.1.2.1. By Mode of Delivery
      • 14.8.1.2.2. By System Type
      • 14.8.1.2.3. By Component
      • 14.8.1.2.4. By End User
  • 14.8.2. Brazil Clinical Trial Management System Market Analysis
    • 14.8.2.1. Introduction
    • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.2.2.1. By Mode of Delivery
      • 14.8.2.2.2. By System Type
      • 14.8.2.2.3. By Component
      • 14.8.2.2.4. By End User
  • 14.8.3. Argentina Clinical Trial Management System Market Analysis
    • 14.8.3.1. Introduction
    • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.3.2.1. By Mode of Delivery
      • 14.8.3.2.2. By System Type
      • 14.8.3.2.3. By Component
      • 14.8.3.2.4. By End User

15. Europe Clinical Trial Management System Market Analysis 2019-2023 and Forecast 2024-2033

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 15.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
  • 15.3.1. By Country
    • 15.3.1.1. Germany
    • 15.3.1.2. Italy
    • 15.3.1.3. France
    • 15.3.1.4. U.K.
    • 15.3.1.5. Spain
    • 15.3.1.6. BENELUX
    • 15.3.1.7. Russia
    • 15.3.1.8. Rest of Europe
  • 15.3.2. By Mode of Delivery
  • 15.3.3. By System Type
  • 15.3.4. By Component
  • 15.3.5. By End User
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Mode of Delivery
  • 15.4.3. By System Type
  • 15.4.4. By Component
  • 15.4.5. By End User
• 15.5. Market Trends
• 15.6. Drivers and Restraints - Impact Analysis
• 15.7. Key Players - Intensity Mapping
• 15.8. Country Level Analysis & Forecast
  • 15.8.1. Germany Clinical Trial Management System Market Analysis
    • 15.8.1.1. Introduction
    • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.1.2.1. By Mode of Delivery
      • 15.8.1.2.2. By System Type
      • 15.8.1.2.3. By Component
      • 15.8.1.2.4. By End User
  • 15.8.2. Italy Clinical Trial Management System Market Analysis
    • 15.8.2.1. Introduction
    • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.2.2.1. By Mode of Delivery
      • 15.8.2.2.2. By System Type
      • 15.8.2.2.3. By Component
      • 15.8.2.2.4. By End User
  • 15.8.3. France Clinical Trial Management System Market Analysis
    • 15.8.3.1. Introduction
    • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.3.2.1. By Mode of Delivery
      • 15.8.3.2.2. By System Type
      • 15.8.3.2.3. By Component
      • 15.8.3.2.4. By End User
  • 15.8.4. U.K. Clinical Trial Management System Market Analysis
    • 15.8.4.1. Introduction
    • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.4.2.1. By Mode of Delivery
      • 15.8.4.2.2. By System Type
      • 15.8.4.2.3. By Component
      • 15.8.4.2.4. By End User
  • 15.8.5. Spain Clinical Trial Management System Market Analysis
    • 15.8.5.1. Introduction
    • 15.8.5.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.5.2.1. By Mode of Delivery
      • 15.8.5.2.2. By System Type
      • 15.8.5.2.3. By Component
      • 15.8.5.2.4. By End User
  • 15.8.6. BENELUX Clinical Trial Management System Market Analysis
    • 15.8.6.1. Introduction
    • 15.8.6.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.6.2.1. By Mode of Delivery
      • 15.8.6.2.2. By System Type
      • 15.8.6.2.3. By Component
      • 15.8.6.2.4. By End User
  • 15.8.7. Russia Clinical Trial Management System Market Analysis
    • 15.8.7.1. Introduction
    • 15.8.7.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.7.2.1. By Mode of Delivery
      • 15.8.7.2.2. By System Type
      • 15.8.7.2.3. By Component
      • 15.8.7.2.4. By End User

16. East Asia Clinical Trial Management System Market Analysis 2019-2023 and Forecast 2024-2033

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 16.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
  • 16.3.1. By Country
    • 16.3.1.1. China
    • 16.3.1.2. Japan
    • 16.3.1.3. South Korea
  • 16.3.2. By Mode of Delivery
  • 16.3.3. By System Type
  • 16.3.4. By Component
  • 16.3.5. By End User
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Mode of Delivery
  • 16.4.3. By System Type
  • 16.4.4. By Component
  • 16.4.5. By End User
• 16.5. Market Trends
• 16.6. Drivers and Restraints - Impact Analysis
• 16.7. Key Players - Intensity Mapping
• 16.8. Country Level Analysis & Forecast
  • 16.8.1. China Clinical Trial Management System Market Analysis
    • 16.8.1.1. Introduction
    • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.1.2.1. By Mode of Delivery
      • 16.8.1.2.2. By System Type
      • 16.8.1.2.3. By Component
      • 16.8.1.2.4. By End User
  • 16.8.2. Japan Clinical Trial Management System Market Analysis
    • 16.8.2.1. Introduction
    • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.2.2.1. By Mode of Delivery
      • 16.8.2.2.2. By System Type
      • 16.8.2.2.3. By Component
      • 16.8.2.2.4. By End User
  • 16.8.3. South Korea Clinical Trial Management System Market Analysis
    • 16.8.3.1. Introduction
    • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.3.2.1. By Mode of Delivery
      • 16.8.3.2.2. By System Type
      • 16.8.3.2.3. By Component
      • 16.8.3.2.4. By End User

17. South Asia Clinical Trial Management System Market Analysis 2019-2023 and Forecast 2024-2033

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 17.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
  • 17.3.1. By Country
    • 17.3.1.1. India
    • 17.3.1.2. Indonesia
    • 17.3.1.3. Malaysia
    • 17.3.1.4. Thailand
    • 17.3.1.5. Rest of South Asia
  • 17.3.2. By Mode of Delivery
  • 17.3.3. By System Type
  • 17.3.4. By Component
  • 17.3.5. By End User
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Mode of Delivery
  • 17.4.3. By System Type
  • 17.4.4. By Component
  • 17.4.5. By End User
• 17.5. Market Trends
• 17.6. Drivers and Restraints - Impact Analysis
• 17.7. Key Players - Intensity Mapping
• 17.8. Country Level Analysis & Forecast
  • 17.8.1. India Clinical Trial Management System Market Analysis
    • 17.8.1.1. Introduction
    • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.1.2.1. By Mode of Delivery
      • 17.8.1.2.2. By System Type
      • 17.8.1.2.3. By Component
      • 17.8.1.2.4. By End User
  • 17.8.2. Indonesia Clinical Trial Management System Market Analysis
    • 17.8.2.1. Introduction
    • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.2.2.1. By Mode of Delivery
      • 17.8.2.2.2. By System Type
      • 17.8.2.2.3. By Component
      • 17.8.2.2.4. By End User
  • 17.8.3. Malaysia Clinical Trial Management System Market Analysis
    • 17.8.3.1. Introduction
    • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.3.2.1. By Mode of Delivery
      • 17.8.3.2.2. By System Type
      • 17.8.3.2.3. By Component
      • 17.8.3.2.4. By End User
  • 17.8.4. Thailand Clinical Trial Management System Market Analysis
    • 17.8.4.1. Introduction
    • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.4.2.1. By Mode of Delivery
      • 17.8.4.2.2. By System Type
      • 17.8.4.2.3. By Component
      • 17.8.4.2.4. By End User

18. Oceania Clinical Trial Management System Market 2019-2023 and Forecast 2024-2033

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 18.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
  • 18.3.1. By Country
    • 18.3.1.1. Australia
    • 18.3.1.2. New Zealand
  • 18.3.2. By Mode of Delivery
  • 18.3.3. By System Type
  • 18.3.4. By Component
  • 18.3.5. By End User
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Mode of Delivery
  • 18.4.3. By System Type
  • 18.4.4. By Component
  • 18.4.5. By End User
• 18.5. Market Trends
• 18.6. Drivers and Restraints - Impact Analysis
• 18.7. Key Players - Intensity Mapping
• 18.8. Country Level Analysis & Forecast
  • 18.8.1. Australia Clinical Trial Management System Market Analysis
    • 18.8.1.1. Introduction
    • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.1.2.1. By Mode of Delivery
      • 18.8.1.2.2. By System Type
      • 18.8.1.2.3. By Component
      • 18.8.1.2.4. By End User
  • 18.8.2. New Zealand Clinical Trial Management System Market Analysis
    • 18.8.2.1. Introduction
    • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.2.2.1. By Mode of Delivery
      • 18.8.2.2.2. By System Type
      • 18.8.2.2.3. By Component
      • 18.8.2.2.4. By End User

19. Middle East and Africa (MEA) Clinical Trial Management System Market Analysis 2019-2023 and Forecast 2024-2033

• 19.1. Introduction
• 19.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 19.3. Current and Future Market Value (US$ Bn) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
  • 19.3.1. By Country
    • 19.3.1.1. GCC Countries
    • 19.3.1.2. Turkey
    • 19.3.1.3. North Africa
    • 19.3.1.4. South Africa
    • 19.3.1.5. Rest of Middle East and Africa
  • 19.3.2. By Mode of Delivery
  • 19.3.3. By System Type
  • 19.3.4. By Component
  • 19.3.5. By End User
• 19.4. Market Attractiveness Analysis
  • 19.4.1. By Country
  • 19.4.2. By Mode of Delivery
  • 19.4.3. By System Type
  • 19.4.4. By Component
  • 19.4.5. By End User
• 19.5. Market Trends
• 19.6. Drivers and Restraints - Impact Analysis
• 19.7. Key Players - Intensity Mapping
• 19.8. Country Level Analysis & Forecast
  • 19.8.1. GCC Countries Clinical Trial Management System Market Analysis
    • 19.8.1.1. Introduction
    • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.1.2.1. By Mode of Delivery
      • 19.8.1.2.2. By System Type
      • 19.8.1.2.3. By Component
      • 19.8.1.2.4. By End User
  • 19.8.2. Turkey Clinical Trial Management System Market Analysis
    • 19.8.2.1. Introduction
    • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.2.2.1. By Mode of Delivery
      • 19.8.2.2.2. By System Type
      • 19.8.2.2.3. By Component
      • 19.8.2.2.4. By End User
  • 19.8.3. South Africa Clinical Trial Management System Market Analysis
    • 19.8.3.1. Introduction
    • 19.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.3.2.1. By Mode of Delivery
      • 19.8.3.2.2. By System Type
      • 19.8.3.2.3. By Component
      • 19.8.3.2.4. By End User
  • 19.8.4. North Africa Clinical Trial Management System Market Analysis
    • 19.8.4.1. Introduction
    • 19.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.4.2.1. By Mode of Delivery
      • 19.8.4.2.2. By System Type
      • 19.8.4.2.3. By Component
      • 19.8.4.2.4. By End User

20. Market Structure Analysis

• 20.1. Market Analysis by Tier of Companies
• 20.2. Market Share Analysis of Top Players
• 20.3. Market Presence Analysis

21. Competition Analysis

• 21.1. Competition Dashboard
• 21.2. Competition Deep Dive
  • 21.2.1. Oracle Corporation
    • 21.2.1.1. Overview
    • 21.2.1.2. Product Portfolio
    • 21.2.1.3. Sales Footprint
    • 21.2.1.4. Key Financials
    • 21.2.1.5. SWOT Analysis
    • 21.2.1.6. Strategy Overview
      • 21.2.1.6.1. Marketing Strategy
      • 21.2.1.6.2. Product Strategy
      • 21.2.1.6.3. Channel Strategy
  • 21.2.2. Merge Healthcare Incorporated
    • 21.2.2.1. Overview
    • 21.2.2.2. Product Portfolio
    • 21.2.2.3. Sales Footprint
    • 21.2.2.4. Key Financials
    • 21.2.2.5. SWOT Analysis
    • 21.2.2.6. Strategy Overview
      • 21.2.2.6.1. Marketing Strategy
      • 21.2.2.6.2. Product Strategy
      • 21.2.2.6.3. Channel Strategy
  • 21.2.3. Medidata Solutions Inc.
    • 21.2.3.1. Overview
    • 21.2.3.2. Product Portfolio
    • 21.2.3.3. Sales Footprint
    • 21.2.3.4. Key Financials
    • 21.2.3.5. SWOT Analysis
    • 21.2.3.6. Strategy Overview
      • 21.2.3.6.1. Marketing Strategy
      • 21.2.3.6.2. Product Strategy
      • 21.2.3.6.3. Channel Strategy
  • 21.2.4. PAREXEL International Corporation
    • 21.2.4.1. Overview
    • 21.2.4.2. Product Portfolio
    • 21.2.4.3. Sales Footprint
    • 21.2.4.4. Key Financials
    • 21.2.4.5. SWOT Analysis
    • 21.2.4.6. Strategy Overview
      • 21.2.4.6.1. Marketing Strategy
      • 21.2.4.6.2. Product Strategy
      • 21.2.4.6.3. Channel Strategy
  • 21.2.5. BioClinica
    • 21.2.5.1. Overview
    • 21.2.5.2. Product Portfolio
    • 21.2.5.3. Sales Footprint
    • 21.2.5.4. Key Financials
    • 21.2.5.5. SWOT Analysis
    • 21.2.5.6. Strategy Overview
      • 21.2.5.6.1. Marketing Strategy
      • 21.2.5.6.2. Product Strategy
      • 21.2.5.6.3. Channel Strategy
  • 21.2.6. MedNet Solutions, Inc.
    • 21.2.6.1. Overview
    • 21.2.6.2. Product Portfolio
    • 21.2.6.3. Sales Footprint
    • 21.2.6.4. Key Financials
    • 21.2.6.5. SWOT Analysis
    • 21.2.6.6. Strategy Overview
      • 21.2.6.6.1. Marketing Strategy
      • 21.2.6.6.2. Product Strategy
      • 21.2.6.6.3. Channel Strategy
  • 21.2.7. Bio-Optronics, Inc.
    • 21.2.7.1. Overview
    • 21.2.7.2. Product Portfolio
    • 21.2.7.3. Sales Footprint
    • 21.2.7.4. Key Financials
    • 21.2.7.5. SWOT Analysis
    • 21.2.7.6. Strategy Overview
      • 21.2.7.6.1. Marketing Strategy
      • 21.2.7.6.2. Product Strategy
      • 21.2.7.6.3. Channel Strategy
  • 21.2.8. DSG, Inc.
    • 21.2.8.1. Overview
    • 21.2.8.2. Product Portfolio
    • 21.2.8.3. Sales Footprint
    • 21.2.8.4. Key Financials
    • 21.2.8.5. SWOT Analysis
    • 21.2.8.6. Strategy Overview
      • 21.2.8.6.1. Marketing Strategy
      • 21.2.8.6.2. Product Strategy
      • 21.2.8.6.3. Channel Strategy
  • 21.2.9. eClinForce, Inc.
    • 21.2.9.1. Overview
    • 21.2.9.2. Product Portfolio
    • 21.2.9.3. Sales Footprint
    • 21.2.9.4. Key Financials
    • 21.2.9.5. SWOT Analysis
    • 21.2.9.6. Strategy Overview
      • 21.2.9.6.1. Marketing Strategy
      • 21.2.9.6.2. Product Strategy
      • 21.2.9.6.3. Channel Strategy
  • 21.2.10. Forte Research Systems, Inc.
    • 21.2.10.1. Overview
    • 21.2.10.2. Product Portfolio
    • 21.2.10.3. Sales Footprint
    • 21.2.10.4. Key Financials
    • 21.2.10.5. SWOT Analysis
    • 21.2.10.6. Strategy Overview
      • 21.2.10.6.1. Marketing Strategy
      • 21.2.10.6.2. Product Strategy
      • 21.2.10.6.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology

관련자료